Posttranscriptional regulation of Fas (CD95) ligand killing activity by lipid rafts.
Fas (CD95/Apo-1) ligand-mediated apoptosis induction of target cells is one of the major effector mechanisms by which cytotoxic lymphocytes (T cells and natural killer cells) kill their target cells. In T cells, Fas ligand expression is tightly regulated at a transcriptional level through the activation of a distinct set of transcription factors. Increasing evidence, however, supports an important role for posttranscriptional regulation of Fas ligand expression and activity. Lipid rafts are cholesterol- and sphingolipid-rich membrane microdomains, critically involved in the regulation of membrane receptor signaling complexes through the clustering and concentration of signaling molecules. Here, we now provide evidence that Fas ligand is constitutively localized in lipid rafts of FasL transfectants and primary T cells. Importantly, disruption of lipid rafts strongly reduces the apoptosis-inducing activity of Fas ligand. Localization to lipid rafts appears to be predominantly mediated by the characteristic cytoplasmic proline-rich domain of Fas ligand because mutations of this domain result in reduced recruitment to lipid rafts and attenuated Fas ligand killing activity. We conclude that Fas ligand clustering in lipid rafts represents an important control mechanism in the regulation of T cell-mediated cytotoxicity.
Nachbur
Ueli
U
Division of Immunopathology, Institute of Pathology, University of Bern, Murtenstr 31, 3010 Bern, Switzerland.
Kassahn
Daniela
D
Yousefi
Shida
S
Legler
Daniel F
DF
Brunner
Thomas
T
D015703:Antigens, CD / Q000276:immunology; D002460:Cell Line; D003602:Cytotoxicity, Immunologic; D053222:Fas Ligand Protein; D006801:Humans; D007668:Kidney; D007694:Killer Cells, Natural / Q000276:immunology; D008562:Membrane Glycoproteins / Q000276:immunology*; D021962:Membrane Microdomains / Q000276:immunology*; D010957:Plasmids; D011499:Protein Processing, Post-Translational; D013601:T-Lymphocytes / Q000276:immunology*; D014162:Transfection; D048069:Tumor Necrosis Factors / Q000276:immunology*; D019014:fas Receptor / Q000276:immunology*
D015703:Antigens, CD; C505661:FASLG protein, human; D053222:Fas Ligand Protein; D008562:Membrane Glycoproteins; D048069:Tumor Necrosis Factors; D019014:fas Receptor